# ImmunityBio, Inc.: Form 8-K, filed Jun 12, 2020

- Company: [ImmunityBio, Inc.](/companies/ibrx.md) (CIK 1326110)
- Form: 8-K
- Filed: 2020-06-12
- Accepted by EDGAR: Jun 11, 2020, 18:25 ET
- Period: 2020-06-10
- Accession: 0001193125-20-166829
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1326110/000119312520166829/d933372d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326110/000119312520166829/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326110/000119312520166829/d933372d8k.htm

Filed Jun 12, 2020.
Source: SEC EDGAR, the filing index for accession 0001193125-20-166829. Last ingested by Listed: Nov 9, 2026, 17:45 ET. No prices; not investment advice.
